UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 594

Sortiert nach

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Frontiers in immunology, 2024, Vol.15, p.1382318-1382318

2024

Volltextzugriff (PDF)

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Volltextzugriff (PDF)

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

Journal of virology, 2017-05, Vol.91 (10)

2017

Volltextzugriff (PDF)

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Nature communications, 2015-12, Vol.6 (1), p.10224, Article 10224

2015

Volltextzugriff (PDF)

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Frontiers in immunology, 2024-04, Vol.15, p.1377374-1377374

2024

Volltextzugriff (PDF)

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Volltextzugriff (PDF)

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Journal of virology, 2015-09, Vol.89 (17), p.8974-8981

2015

Volltextzugriff (PDF)

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in immunology, 2024-05, Vol.15, p.1374818-1374818

2024

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Volltextzugriff (PDF)

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Science (American Association for the Advancement of Science), 2013-05, Vol.340 (6136), p.1113-1117

2013

Volltextzugriff (PDF)

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Virology (New York, N.Y.), 2015-02, Vol.476, p.217-225

2015

Volltextzugriff (PDF)

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Vaccine, 2012-07, Vol.30 (35), p.5206-5214

2012

Volltextzugriff (PDF)

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

The Journal of immunology (1950), 2016-02, Vol.196 (4), p.1721-1731

2016

Volltextzugriff (PDF)

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

Journal of virology, 2017-10, Vol.91 (19)

2017

Volltextzugriff (PDF)

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

Journal of Virology, 2010-01, Vol.84 (2), p.1148-1157

2010

Volltextzugriff (PDF)

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Virology (New York, N.Y.), 2016-12, Vol.499, p.288-297

2016

Volltextzugriff (PDF)

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Journal of Virology, 2012-05, Vol.86 (10), p.5422-5436

2012

Volltextzugriff (PDF)

Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection

PLoS pathogens, 2018-01, Vol.14 (1), p.e1006810-e1006810

2018

Volltextzugriff (PDF)

The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia

The Journal of immunology (1950), 2008-12, Vol.181 (11), p.7958-7968

2008

Volltextzugriff (PDF)

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Journal of allergy and clinical immunology, 2017-10, Vol.140 (4), p.1068-1078.e6

2017

Volltextzugriff (PDF)

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

Vaccine, 2013-04, Vol.31 (17), p.2169-2176

2013

Volltextzugriff (PDF)

The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection

Journal of Virology, 2013-09, Vol.87 (18), p.10070-10082

2013

Volltextzugriff (PDF)

IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease

The Journal of immunology (1950), 2008-02, Vol.180 (4), p.2376-2384

2008

Volltextzugriff (PDF)

CD8 T Cells Inhibit Respiratory Syncytial Virus (RSV) Vaccine-Enhanced Disease

Journal of Immunology, 2007-10, Vol.179 (8), p.5415-5424

2007

Volltextzugriff (PDF)

1 – 25 von 594

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(588)
Mit Volltextzugriff
(551)

Publikationsform

Artikel
(594)

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(594)
Science & Technology
(548)
Life Sciences & Biomedicine
(496)
Mice, Inbred Balb C
(484)
Respiratory Syncytial Virus
(412)
Respiratory Syncytial Virus Infections - Immunology
(342)
Immunology
(276)
Respiratory Syncytial Viruses - Immunology
(265)
Humans
(247)
Virology
(238)
Biological And Medical Sciences
(194)
Lung - Immunology
(158)
Lung - Virology
(156)
Microbiology
(156)
Respiratory Syncytial Virus Infections - Prevention & Control
(148)
Fundamental And Applied Biological Sciences. Psychology
(142)
Lung - Pathology
(132)
Respiratory Syncytial Virus Infections - Virology
(131)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(83)
Vaccine
(63)
The Journal Of Immunology
(41)
Plos One
(39)
The journal Of Immunology/the journal Of Immunology
(38)
The Journal Of Infectious Diseases
(19)
Virology
(16)
The journal Of Infectious Diseases
(14)
Journal Of Medical Virology
(13)
Frontiers In Immunology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection

The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection

IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease

CD8 T Cells Inhibit Respiratory Syncytial Virus (RSV) Vaccine-Enhanced Disease

Aktive Filter

Suchergebnisse filtern